Minimally invasive glaucoma surgery (MIGS) isn’t just for mild to moderate conditions. It is safer and may be more effective than tube shunts in patients with uveitic and steroid-induced glaucoma.
Glaucoma specialist Shalini Sood-Mendiratta, MD, has begun lending home tonometry units to her patients. At-home monitoring can reveal pressure fluctuations not evident at office visits.
A team of Cleveland Clinic researchers is developing an “intelligent” contact lens to continuously measure intraocular pressure (IOP) throughout the day.
A 29-year-old man with optic disc cupping and retinal detachment was diagnosed with Schwartz-Matsuo glaucoma. After reattachment surgery and gonioscopy-assisted transluminal trabeculotomy, his IOP is well controlled on medications.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A 68-year-old man with poorly controlled unilateral open-angle glaucoma gets an unexpected diagnosis, and successful treatment.
Using minimally invasive glaucoma surgery as an adjunct to cataract surgery safely restores vision and reduces intraocular pressure in patients with pre-existing mild-to-moderate stage glaucoma.
Cleveland Clinic researchers demonstrate cell-specific responses to extracellular viruses, which may be helpful in uncovering the mechanisms behind determining a cell’s fate.
Best practice surgery for glaucoma is changing fast. University of Colorado School of Medicine ophthalmology professor and Chief of Glaucoma Services discusses how with MIGS, surgeons can choose from more treatment options on the market or on the way to it.
Ongoing global analyses can identify biomarker candidates for targeted quantitative proteomic analyses. Knowledge gained can guide future diagnoses and treatments for AMD and glaucoma.
Learn more about the latest in glaucoma news, treatments, research and innovations, from Cleveland Clinic’s Cole Eye Institute and industry experts.